Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis. | ClinicLens
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), used to treat type 2 diabetes and obesity, may improve metabolic health before conception. However, their association to hypertensive disorders of pregnancy (HDP) after periconceptional or early pregnancy exposure remains unk
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.